Besivance and Keratopathy band - a phase IV clinical study of FDA data
We study 1,007 people who take Besivance or have Keratopathy band. No report of Keratopathy band is found in people who take Besivance.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Besivance?
Besivance has active ingredients of besifloxacin hydrochloride. eHealthMe is studying from 1,000 Besivance users for its effectiveness, alternative drugs and more.
What is Keratopathy Band?
Keratopathy band is found to be associated with 8 drugs by eHealthMe.
Do you take Besivance and have Keratopathy band?Check whether Keratopathy band is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keratopathy band and when was it recovered:
Expand to all the drugs that have ingredients of besifloxacin hydrochloride:
Alternative drugs to, pros and cons of Besivance:
- Besivance (1,000 reports)
Keratopathy band treatments and more:
- Keratopathy band (7 reports)
COVID vaccines that are related to Keratopathy band:
- Keratopathy band in Moderna COVID Vaccine
- Keratopathy band in Pfizer BioNTech Covid Vaccine
- Keratopathy band in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keratopathy band:
All the conditions that are associated with Keratopathy band:
How the study uses the data?
The study uses data from the FDA. It is based on besifloxacin hydrochloride (the active ingredients of Besivance) and Besivance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Proventil and Gastroenteritis Viral - 5 seconds ago
- Depo-Testosterone and Decreased Activity - 7 seconds ago
- Norco and Post Procedural Haematoma - 10 seconds ago
- Ibu and Paronychia - 11 seconds ago
- Zoledronic Acid and Olmetec drug interaction - 16 seconds ago
- Calcitriol and Steal Syndrome - 18 seconds ago
- Vesanoid and Mucosal Inflammation - 18 seconds ago
- Meloxicam and Erection Problems - 19 seconds ago
- Bactrim Ds and Asthenopia - 20 seconds ago
- Celecoxib and Pamidronate Disodium drug interaction - 24 seconds ago